Cargando…

TDP43 promotes stemness of breast cancer stem cells through CD44 variant splicing isoforms

Alternative splicing (AS) is a promising clinical target for cancer treatment at the post-transcriptional level. We previously identified a unique AS profile in triple-negative breast cancer (TNBC), which is regulated by the splicing regulator TAR DNA-binding protein-43 (TDP43), thus indicating the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Lu, Ke, Hao, Zhang, Honglei, Zou, Li, Yang, Qin, Lu, Xuemei, Zhao, Limin, Jiao, Baowei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065105/ https://www.ncbi.nlm.nih.gov/pubmed/35504883 http://dx.doi.org/10.1038/s41419-022-04867-w

Ejemplares similares

Implications of TDP-43 in non-neuronal systems
por: Ke, Hao, et al.
Publicado: (2023)

Loss of TDP43 inhibits progression of triple-negative breast cancer in coordination with SRSF3
por: Ke, Hao, et al.
Publicado: (2018)

A C-Terminally Truncated TDP-43 Splice Isoform Exhibits Neuronal Specific Cytoplasmic Aggregation and Contributes to TDP-43 Pathology in ALS
por: Shenouda, Marc, et al.
Publicado: (2022)

TDP-43 facilitates milk lipid secretion by post-transcriptional regulation of Btn1a1 and Xdh
por: Zhao, Limin, et al.
Publicado: (2020)

CD44 splice isoform switching determines breast cancer stem cell state
por: Zhang, Honghong, et al.
Publicado: (2019)

TDP-43 affects splicing profiles and isoform production of genes involved in the apoptotic and mitotic cellular pathways
por: De Conti, Laura, et al.
Publicado: (2015)

Structural Characterization of the CD44 Stem Region for Standard and Cancer-Associated Isoforms
por: Chen, Kun-Lin, et al.
Publicado: (2020)

Quantitative analysis of cryptic splicing associated with TDP-43 depletion
por: Humphrey, Jack, et al.
Publicado: (2017)

The N-terminal dimerization is required for TDP-43 splicing activity
por: Jiang, Lei-Lei, et al.
Publicado: (2017)

Phase separation-deficient TDP43 remains functional in splicing
por: Schmidt, Hermann Broder, et al.
Publicado: (2019)

SUMOylation Regulates TDP-43 Splicing Activity and Nucleocytoplasmic Distribution
por: Maraschi, AnnaMaria, et al.
Publicado: (2021)

Studies of alternative isoforms provide insight into TDP-43 autoregulation and pathogenesis
por: D'Alton, Simon, et al.
Publicado: (2015)

CD44 Staining of Cancer Stem-Like Cells Is Influenced by Down-Regulation of CD44 Variant Isoforms and Up-Regulation of the Standard CD44 Isoform in the Population of Cells That Have Undergone Epithelial-to-Mesenchymal Transition
por: Biddle, Adrian, et al.
Publicado: (2013)

Initiation and Maintenance of Gastric Cancer: A Focus on CD44 Variant Isoforms and Cancer Stem Cells
por: Zavros, Yana
Publicado: (2017)

Expression and modulation of CD44 variant isoforms in humans
Publicado: (1994)

TDP-43 and Limbic-Predominant Age-Related TDP-43 Encephalopathy
por: Zhang, Lumi, et al.
Publicado: (2020)

DCTN1 Binds to TDP-43 and Regulates TDP-43 Aggregation
por: Deshimaru, Manami, et al.
Publicado: (2021)

Disease‐linked TDP‐43 hyperphosphorylation suppresses TDP‐43 condensation and aggregation
por: Gruijs da Silva, Lara A, et al.
Publicado: (2022)

CD44 Variant Isoform Expression and Breast Cancer Prognosis
por: Tokue, Yutaka, et al.
Publicado: (1998)

CD44V3, an Alternatively Spliced Form of CD44, Promotes Pancreatic Cancer Progression
por: Zhu, Hanzhang, et al.
Publicado: (2022)

Rodent Models of TDP-43 Proteinopathy: Investigating the Mechanisms of TDP-43-Mediated Neurodegeneration
por: Gendron, Tania F., et al.
Publicado: (2011)

Chaperone Mediated Autophagy Degrades TDP-43 Protein and Is Affected by TDP-43 Aggregation
por: Ormeño, Fernando, et al.
Publicado: (2020)

TDP-43 protein variants as biomarkers in amyotrophic lateral sclerosis
por: Williams, Stephanie M., et al.
Publicado: (2017)

Lack of association between TDP-43 pathology and tau mis-splicing in Alzheimer's disease
por: Niblock, Michael, et al.
Publicado: (2016)

Cell senescence, loss of splicing, and lipid metabolism in TDP-43-related neurodegenerative processes
por: Torres, Pascual, et al.
Publicado: (2023)

TDP-43 crosses the divide
por: Leslie, Mitch
Publicado: (2015)

Expression of CD44 Variant Isoforms in Normal and Neoplastic Cells of the Lung
por: Washimi, Osuke, et al.
Publicado: (1994)

Cytoplasmic mislocalization of RNA splicing factors and aberrant neuronal gene splicing in TDP-43 transgenic pig brain
por: Wang, Guohao, et al.
Publicado: (2015)

CD44 standard and CD44v10 isoform expression on leukemia cells distinctly influences niche embedding of hematopoietic stem cells
por: Erb, Ulrike, et al.
Publicado: (2014)

TDP-43: From Alzheimer’s Disease to Limbic-Predominant Age-Related TDP-43 Encephalopathy
por: Huang, Wendi, et al.
Publicado: (2020)

TDP-43 mislocalization drives neurofilament changes in a novel model of TDP-43 proteinopathy
por: Atkinson, Rachel, et al.
Publicado: (2021)

The cooperative binding of TDP-43 to GU-rich RNA repeats antagonizes TDP-43 aggregation
por: Rengifo-Gonzalez, Juan Carlos, et al.
Publicado: (2021)

Aggregation-prone TDP-43 sequesters and drives pathological transitions of free nuclear TDP-43
por: Keating, Sean S., et al.
Publicado: (2023)

Evidence of cerebellar TDP-43 loss of function in FTLD-TDP
por: Pickles, Sarah, et al.
Publicado: (2022)

Spreading of TDP-43 pathology via pyramidal tract induces ALS-like phenotypes in TDP-43 transgenic mice
por: Ding, Xuebing, et al.
Publicado: (2021)

Antibody against TDP-43 phosphorylated at serine 375 suggests conformational differences of TDP-43 aggregates among FTLD–TDP subtypes
por: Neumann, Manuela, et al.
Publicado: (2020)

The Pathological Phenotypes of Human TDP-43 Transgenic Mouse Models Are Independent of Downregulation of Mouse Tdp-43
por: Xu, Ya-Fei, et al.
Publicado: (2013)

TDP-43 and Phosphorylated TDP-43 Levels in Paired Plasma and CSF Samples in Amyotrophic Lateral Sclerosis
por: Ren, Yuting, et al.
Publicado: (2021)

TREM2 interacts with TDP-43 and mediates microglial neuroprotection against TDP-43-related neurodegeneration
por: Xie, Manling, et al.
Publicado: (2021)

Monomerization of TDP-43 is a key determinant for inducing TDP-43 pathology in amyotrophic lateral sclerosis
por: Oiwa, Kotaro, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5kqn43eis2p1lqr6mu7p9i0i0j